Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$120,165,474
in 11 filings, $3.7M under 10b5-1 plans

Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SVF Pauling (Cayman) Ltd −$116.4M 10% owner sold 22% of stake
  2. Patel Sanjiv −$2.8M President and CEO sold 23% of stake
  3. Catinazzo Thomas −$692K Chief Financial Officer sold 26% of stake
  4. Bergstrom Donald A −$204K President, R&D sold 3% of stake
  5. Rahmer Peter −$104K See remarks sold 2% of stake

Reading 98 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-30 Patel Sanjiv President and CEO Grant or award +1,662 $10.68 $18K 1,662
2023-06-30 Bergstrom Donald A President, R&D Grant or award +1,228 $10.68 $13K 241,815
2023-06-30 Rahmer Peter See remarks Grant or award +1,662 $10.68 $18K 319,822
2023-06-27 Rahmer Peter See remarks Sale −244 $12.12 $3K 318,160
2023-06-27 Catinazzo Thomas Chief Financial Officer Sale −294 $12.12 $4K 147,829
2023-06-27 Bergstrom Donald A President, R&D Sale −647 $12.12 $8K 240,587
2023-06-27 Adams Brian Chief Legal Officer Sale −294 $12.12 $4K 133,515
2023-05-31 HILL LINDA A Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 INGRAM DOUGLAS S Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 Kathiresan Sekar Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 Rubin Jami Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 Shawver Laura Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-31 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +66,055 66,055
2023-05-30 Rahmer Peter See remarks Grant or award +161,818 318,404
2023-05-24 Shawver Laura Director Gift −12,099 40,000
2023-04-28 Rahmer Peter See remarks Sale −1,657 $11.16 $18K 156,586
2023-04-28 Catinazzo Thomas Chief Financial Officer Sale −2,012 $11.16 $22K 148,123
2023-04-28 Bergstrom Donald A President, R&D Sale −2,850 $11.16 $32K 241,234
2023-04-28 Adams Brian Chief Legal Officer Sale −1,936 $11.16 $22K 133,809

Page 12 of 17 · 329 trades